The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary macroadenoma
Abstract
Summary: Background The differentiation of a pituitary non‐functioning macroadenoma from a macroprolactinoma is important for planning appropriate therapy. Serum PRL levels have been suggested as a useful diagnostic indicator. However, values between 2500 and 8000 mU/l are a grey area and are currently associated with diagnostic uncertainty. Objective We wished therefore, to investigate the serum PRL values in a large series of patients presenting with apparently non‐functioning pituitary macroadenomas. Patients and methods All patients presenting to the Department of Endocrinology in Oxford with clinically non‐functioning pituitary macroadenomas (later histologically verified) between 1990 and 2005 were studied. Information documented in the notes on the medications and on the presence of conditions capable of affecting the serum PRL levels at the time of blood sampling was also collected. Results Two hundred and twenty‐six patients were identified (median age at diagnosis 55 years, range 18–88 years; 146 males/80 females; 143 gonadotroph, 46 null cell, 25 plurihormonal and 12 silent ACTH adenomas). All tumours had suprasellar extension. At the time of blood sampling 41 subjects were taking medications capable of increasing serum PRL. Hyperprolactinaemia was found in 38·5% (87/226) of the patients. The median serum PRL values in the total group were 386 mU/l (range 16–3257) (males: median 299 mU/l, range 16–1560; females: median 572 mU/l, range 20–3257) and in those not taking drugs capable of increasing serum PRL 363 mU/l (range 16–2565) (males: median 299 mU/l, range 16–1560; females: median 572 mU/l, range 20–2565). Serum PRL < 2000 mU/l was found in 98·7% (223/226) of the total group and in 99·5% (184/185) of those not taking drugs. Among the three subjects with serum PRL > 2000 mU/l, two were taking oestrogen preparations. Conclusions Based on a large series of histologically confirmed cases, serum PRL > 2000 mU/l is almost never encountered in nonfunctioning pituitary macroadenomas. Values above this limit in the presence of a macroadenoma should not be surrounded by diagnostic uncertainty (after acromegaly or Cushing's disease have been excluded); a prolactinoma is the most likely diagnosis and a dopamine agonist should be considered as the treatment of choice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Augmentation of prolactin secretion by estrogen in hypogonadal women
Yen, S. S., Ehara, Y., & Siler, T. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107600 · Cited by 222
Cited by
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Self-citationPetersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00886-5 · Cited by 411
Self-citationSystemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas
Ntali, G., & Wass, J. A. (2018) · Pituitary · doi:10.1007/s11102-018-0869-3 · Cited by 285
Self-citationMolitch, M. E. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.05.001 · Cited by 155
Metadata
- Authors
- Karavitaki, N., Thanabalasingham, G., Shore, H. C. A., Trifanescu, R., Ansorge, O., Meston, N., Turner, H. E., & Wass, J. A. H.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2006-09-18
- Volume
- 65
- Issue
- 4
- Pages
- 524-529
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2077574437
- Cited by
- 230
- References
- 1
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary macroadenoma. https://app.cochat.ai/papers/10.1111/j.1365-2265.2006.02627.x
- The paper
- Karavitaki, N., Thanabalasingham, G., Shore, H. C. A., Trifanescu, R., Ansorge, O., Meston, N., Turner, H. E., & Wass, J. A. H. (2006). Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary macroadenoma. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2006.02627.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.